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Abstract
Background: Bacteriuria, either asymptomatic (ASB) or symptomatic, urinary tract infection (UTI), is common in persons
with spinal cord injury (SCI). Current Veterans Health Administration (VHA) guidelines recommend a screening urinalysis and
urine culture for every veteran with SCI during annual evaluation, even when asymptomatic, which is contrary to other national
guidelines. Our preliminary data suggest that a positive urine culture (even without signs or symptoms of infection) drives antibiotic
use.
Objective: Through a series of innovative studies utilizing mixed methods, administrative databases, and focus groups, we will
gain further knowledge about the attitudes driving current urine testing practices during the annual exam, as well as quantitative
data on the clinical outcomes of these practices.
Methods: Aim 1 will identify patient, provider, and facility factors driving bacteriuria testing and subsequent antibiotic use
after the SCI annual evaluation through qualitative interviews and quantitative surveys. Aim 2 will use national VHA databases
to identify the predictors of urine testing and subsequent antibiotic use during the annual examination and compare the clinical
outcomes of those who received antibiotics with those who did not. Aim 3 will use the information gathered from the previous
2 aims to develop the Test Smart, Treat Smart intervention, a combination of patient and provider education and resources that
will help stakeholders have informed conversations about urine testing and antibiotic use; feasibility will be tested at a single
site.
Results: This protocol received institutional review board and VHA Research and Development approval in July 2017, and
Veterans Affairs Health Services Research and Development funding started on November 2017. As of submission of this
manuscript, 10/15 (67%) of the target goal of provider interviews were complete, and 77/100 (77%) of the goal of surveys. With
regard to patients, 5/15 (33%) of the target goal of interviews were complete, and 20/100 (20%) of the target goal of surveys had
been completed. Preliminary analyses are ongoing; the study team plans to present these results in April 2019. Database analyses
for aim 2 will begin in January 2019.
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Conclusions: The negative consequences of antibiotic overuse and antibiotic resistance are well-documented and have national
and even global implications. This study will develop an intervention aimed to educate stakeholders on evidence-based management
of ASB and UTI and guide antibiotic stewardship in this high-risk population. The next step will be to refine the intervention and
test its feasibility and effectiveness at multiple sites as well as reform policy for management of this common but burdensome
condition.
International Registered Report Identifier (IRRID): DERR1-10.2196/12272
(JMIR Res Protoc 2019;8(2):e12272) doi: 10.2196/12272
KEYWORDS
spinal cord injury; urinary tract infection; patient-focused care; qualitative evaluation; antimicrobial stewardship

Introduction
Background
Antibiotic stewardship (promoting appropriate use of antibiotics)
is a high-level policy and public health initiative, as shown by
recent mandates from the Center for Disease Control and the
United Nations [1,2]. Persons with spinal cord injury (SCI) are
vulnerable to inappropriate antibiotic use because of their
medical complexity and frequent health care contact [3].
Specifically, bacteriuria is a common consequence of neurogenic
bladder after SCI; asymptomatic bacteriuria (ASB) has a
prevalence of 30% to 90% depending on the bladder
management strategy used [4]. For comparison, the prevalence
rate in healthy premenopausal women is 5%. ASB, defined as
the presence of bacteria in the urine of a person not otherwise
having signs or symptoms of a urinary tract infection (UTI),
does not require treatment except in pregnancy and before
urologic procedures [4]. In fact, evidence-based guidelines
published by the Infectious Diseases Society of America
recommend against collecting screening urine cultures or
treating ASB in persons with SCI [4,5]. The Veterans Health
Administration (VHA) guidelines outlining care for persons
with SCI, however, recommend a yearly urinalysis and urine
culture as part of an annual physical checkup, regardless of
whether signs or symptoms of infection are present [6].
Obtaining these tests in asymptomatic patients is essentially a
screening for ASB. Although the VHA guideline does not
explicitly recommend treatment of ASB, review of 2 years of
annual examination visits uncovered that 35% of cases of ASB
were subsequently treated with antibiotics [7].
Our goal is to develop an effective antibiotic stewardship
program for bacteriuria tailored to the SCI population and SCI
providers. To address gaps in knowledge relevant to antibiotic
stewardship in SCI, we will utilize a mixed methods approach.
First, we will answer the following question: do providers and
persons with SCI believe that testing the urine and treating
asymptomatic colonization will lead to better outcomes? We
will explore this by conducting qualitative interviews with
patients with SCI and SCI providers to understand their
perceptions and expectations related to having their urine tested
annually, and being prescribed and adhering to prescribed
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antibiotics, and correlating this information with quantitative
knowledge surveys. Next, we hypothesize that urine testing
during the annual examination leads to antibiotic use, and the
antibiotics, in turn, have downstream consequences. This will
be examined through analysis of VHA data sources. Finally,
we will develop an intervention to more effectively deliver
evidence-based bacteriuria management to persons with SCI.
We hypothesized that the intervention will be feasible to use
and increase patient satisfaction with bacteriuria management
during the annual evaluation.

Conceptual Framework
Cabana et al and others have explored the barriers to successful
implementation of clinical practice guidelines into actual
practice [8]. Clinical practice guidelines for bacteriuria
management are often long and complex, requiring users to
keep a sequential mental record of the statements to arrive at
the diagnosis of UTI or ASB. Clinical practice guidelines may
conflict with the users’ pre-existing biases of the standard of
care, also limiting their use [9,10]. For example, many providers
that take care of persons with SCI believe that treating ASB
from urease-producing organisms such as Proteus species is
beneficial, but the evidence is not convincing toward this
[11,12]. Our project will utilize the Cabana framework to lessen
the diagnostic challenge of distinguishing UTI from ASB.

Methods
Project Design Overview
Figure 1 provides an overview of the project aims. We will
identify contextual factors influencing provider and patient
knowledge and beliefs about urine testing and treatment at the
annual examination, using quantitative and qualitative methods
(aim 1). We will then identify the evidence regarding patient,
provider, and facility predictors of urine testing and subsequent
antibiotic use, as well as compare the clinical outcomes of those
who received antibiotics with the outcomes of those who did
not (aim 2). We will then use information gained from the above
aims and previously successful antibiotic stewardship initiatives
[5] to intervene, by providing evidence-based bacteriuria
management through education and resources for patients and
providers (aim 3).
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Figure 1. Optimizing bacteriuria management in the veteran spinal cord injury population. An overview of the planned project.

To develop an effective intervention to lessen the burden of
utilizing clinical practice guidelines, we need a complete
understanding of the key factors that drive provider testing and
treatment behaviors (eg, knowledge and attitudes) and patient
engagement. We will utilize the Cabana model, as described
above, to understand provider barriers to using clinical practice
guidelines in clinical practice [8]. During the development of
the intervention (aim 3), we will use the concept of intervention
mapping described by Kok et al [13], as well as audit and
feedback, as a main component of the intervention. Intervention
mapping is a process to develop theory- and evidence-based
interventions and involves the following 6 steps: (1) needs
assessment; (2) identification of change objectives; (3) selection
of theory-based intervention methods and practical applications
to enact change; (4) development of intervention components;
(5) intervention adoption, implementation, and maintenance
plan; and (6) plan for evaluation of intervention effectiveness.
Audit and feedback or providing health care professionals with
up-to-date data about their performance, has previously been
shown to improve quality of care and was a successful
component of the Kicking catheter-associated urinary tract
infection (CAUTI) intervention [14,15]. We have also included
a medical anthropologist in our team to explore how
organizational culture intersects with and shapes medical
practices in SCI clinics.

will guide our approach [16]. We are deliberately including
physicians and nonphysician (ie, physician assistants and nurse
practitioners) providers to capture a broad variety of experiences,
and identify overarching themes, across geographically diverse
sites; this sample size will allow for maximum variation in our
data [17]. Our patient sample will be inclusive of factors such
as age, ethnicity or race, and bladder management strategy (ie,
indwelling catheter, intermittent catheter, etc) to capture a wide
range of perspectives.

Aim 1

Following the interviews, all SCI patients and providers will
be invited to participate in phone surveys. Patients who received
a prescription for antibiotics for UTI will be invited to complete
the Morisky Medication Adherence Scale-8 (MMAS-8). This
is an 8-item validated questionnaire to evaluate intentional and
unintentional medication nonadherence [18-20]. Providers will
receive a closed-ended survey to assess knowledge in 6 domains
about bacteriuria management. This is a validated survey used
previously to explore this topic [21].

This aim focuses on identifying patient, provider, and facility
factors driving bacteriuria management in persons with SCI.
We will employ qualitative and quantitative phases to identify
patient, provider, and facility factors driving urine testing and
antibiotic use during the annual evaluation.

Participants and Approach: Qualitative Phase
Semistructured, open-ended interviews will be conducted with
health care providers (n=15) at 5 national VHA SCI outpatient
centers (ie, hub sites) and 2 to 3 of their corresponding satellite
primary care clinics (ie, spoke sites) and SCI patients (n=15).
Maximum variation sampling, a purposeful sampling strategy,
https://www.researchprotocols.org/2019/2/e12272/
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The interview guides are based on the major domains of our
conceptual model. Provider interviews will begin by collecting
demographic information that will include age, level of training,
and information on board certification (physical medicine and
rehabilitation, SCI medicine board-certified, and/or other
specialties). Additional provider questions will focus on the
utility of obtaining an annual urinalysis or urine culture and
attitudes toward antibiotic stewardship. Patient interviews will
begin by collecting demographic information that includes age,
level of injury, numbers of years since injury, and method of
bladder management. Patient interviews will focus on related
topics discussed during the provider interviews, as well as
previous experiences with UTI treatment and medication
adherence.

Participants and Approach: Quantitative Phase

Analysis for Aim 1
Analysis of the qualitative and quantitative data will be
concurrent. For the qualitative analysis, a combined inductive
and deductive coding approach will be used to code the data.
JMIR Res Protoc 2019 | vol. 8 | iss. 2 | e12272 | p. 3
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Moreover, 2 members of the research team (FS and LM) will
read through the transcripts and develop a list of codes, based
on participants’ experiences (inductive) and the subelements of
our conceptual model (deductive). The full research team will
hold regular meetings to discuss results and resolve any
discrepancies in the coding process. Once coding is complete,
individual codes will be sorted (ie, grouped together into like
categories) by the research team to identify larger themes [22].
Qualitative analysis software, Atlas.ti, (Scientific Software
Development GmbH) will be utilized to facilitate the coding
process.
For the quantitative analysis, the patient scores on the MMAS-8
will be reported using descriptive statistics (mean, median,
interquartile range, etc). The provider surveys provide data in
the form of self-report ASB/UTI guidelines familiarity score,
a knowledge score (series of hypothetical clinical scenarios
testing the application of ASB/UTI guidelines), and a
cognitive-behavioral domain score. We have previously used
this survey to assess knowledge and behavior concerning ASB
in acute and long-term care [21]. The knowledge score is the
percentage of correct answers to the hypothetical clinical
scenarios, with each correct response receiving 1 point.
Descriptive statistics will be used to report the mean knowledge
scores for various groups of respondents, and analysis of
variance will be used to compare knowledge scores by provider
type (ie, attending physician, physician assistant, and nurse
practitioner, etc) and level of training. The relationship between
the guideline familiarity score and knowledge score will be
assessed using a Pearson correlation coefficient. The cognitive
behavioral responses in each domain will be averaged to
generate a numerical score for that domain. Correlations between
the cognitive behavioral constructs and knowledge score will
be calculated using the Pearson correlation coefficient.
The quantitative and qualitative data for patient and providers
will then be integrated. For patients, we will integrate the mean
scores on the MMAS-8 to interview responses on adherence to
antibiotics. For providers, we will integrate the knowledge and
guideline familiarity scores from the survey with their interview
responses on familiarity with the guidelines. Congruence and
incongruence between the quantitative and qualitative findings
will be explored; for example, if providers answered in the
affirmative about knowledge of guidelines, we will correlate
the qualitative data with their scores on the knowledge survey.

Aim 2
This objective will determine (1) which patient, provider, and
facility factors are predictors of urine testing and subsequent
antibiotic use during the annual evaluation and (2) compare the
clinical outcomes of those who received antibiotics with the
outcomes of those who did not, utilizing national VHA data
sources. These databases (especially for use in SCI) have been
described previously [23,24]. The corporate data warehouse
(CDW) is a national repository including clinical and
administrative data from the VHA. Data are stored in a relational
database and are updated on a continual basis. We will use data
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from several domains within CDW to obtain demographics on
the patient population (age, gender, race or ethnicity, and marital
status); diagnoses, individual patient utilization (number of
visits and admissions), provider type, and facility characteristics
(SCI center vs non-SCI center and number of visits and
admissions for the facility); temperature and heart rate; and
laboratory data including albumin, creatinine, total white blood
cell count, urea, glucose, hematocrit, electrolyte panels, and
microbiology data (ie, date and time of culture, specimen type,
organisms, and antibiotic susceptibilities). Outpatient
medications to assess antibiotics filled and history of exposure
to antibiotics will be obtained from all available outpatient
pharmacy domains.

Participants
All adult patients with SCI treated at VHA facilities for an
outpatient annual examination during the years 2015 and 2016
will be included. The study sample will be drawn from a
cumulative list of veterans with SCI maintained by the Veterans
Affairs Allocation Resource Center since 1988, which includes
approximately 33,000 patients. Veterans are added to the list
when an administrative record indicates an SCI in the inpatient
diagnostic field with certain International Classification of
Disease (ICD)-10 code.
The inclusion criteria for this aim are veterans who were seen
for their annual examination in the outpatient setting in the VHA
SCI system of care during the years 2015 and 2016
(approximately 6300 veterans are seen each year across the
nation). Exclusion criteria are veterans who were seen for their
SCI annual evaluation in the inpatient setting because visits
may be complicated by other acute medical issues occurring at
the time. The study will also exclude veterans with a history of
genitourinary tract tumors per ICD-10 codes (and, therefore,
more likely to have altered anatomy and/or immunosuppression),
as well as those that died less than a year from the annual
evaluation encounter. Only the first eligible encounter for each
participant will be included. On the basis of our study looking
at bacteriuria management in a single VHA center [7], we
anticipate approximately 6000 participants after applying the
exclusion criteria.

Approach
Aim 2a is to determine which patient, provider, and facility
factors are predictors of urine testing and subsequent antibiotic
use. To identify the annual examination encounter, we will use
outpatient visits in the clinic stop code for SCI (210) that also
has a current procedural terminology code for a renal ultrasound
(usually ordered only during the annual evaluation).
The general schema for this objective is shown in Figure 2. This
is derived from the Cabana model for adherence to clinical
guidelines.
Themes from aim 1 will guide an administrative database search
of clinical outcomes of the current VHA urine testing and
treatment practices.
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Figure 2. Bacteriuria management decision making in the veteran spinal cord injury population.

The variables to be collected are described in Table 1. These
were generated by the preliminary study results [7] and will be
amended, based on other themes identified from objective 1.
Zip codes of addresses will be obtained and given a GeoScore,
a type of neighborhood socioeconomic index that is emerging
as health services and health disparity research and is moving
toward large administrative datasets, and was used by Hamilton
et al exploring socioeconomic impact on health care utilization
after SCI [25]. Deyo comorbidity index will also be calculated
using VHA data sources.
Aim 2b will compare the clinical outcomes of those who
received antibiotics with the outcomes of those who did not.
We will use the same cohort as defined above. Table 2 defines
the exposure and outcome variables, as well as covariates that
will be considered for the second part of this aim.

Analysis for Aim 2
It would be clinically meaningful to show no difference in the
outcomes between the 2 groups as we hypothesized that one
driver of treating ASB at the annual exam is to prevent some
of these negative downstream effects.
We will construct separate logistic regression models to
determine the predictors of the following: (1) urine testing and
(2) the initiation of antibiotics in the 7 days following the annual
examination, with day 1 being the day of the examination. First,
univariate analyses will be performed between each exposure
variable (Table 1) and the outcome variables. Variables that
satisfy a previously established P value criterion (.25) on
univariate analysis will be considered for entry into a
multivariate logistic regression model. We will use a lower P
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value threshold for the univariate analysis to ensure a robust
model. Odds ratios will be used to determine the impact of each
variable on antibiotic use. The alpha of .05 will be used to
determine statistical significance. Multivariable logistic
regression will be used to test all variables for independent
associations. For aim 2b, rates of the above outcomes between
those who received antibiotics versus those who did not will be
compared using chi-square tests for nominal variables and t
tests for continuous variables. The Mann-Whitney nonparametric
U test will be used if the distribution of any continuous variable
is not normal. We will construct a logistic regression model to
determine the effect of antibiotics in the 7 days following the
annual examination on the outcomes defined in Table 2.
Univariate and multivariate analyses will be the same as aim
2a.

Aim 3
The provider components of the Test Smart, Treat Smart
intervention (aim 3a) will be an adaptation of the successful
Kicking CAUTI intervention, consisting of audit and feedback,
visual aids, and order sets, refined for SCI providers using
iterative design. The patient components will be developed more
de novo but be driven by previous work on how patients with
SCI prefer to receive information (combination of internet and
provider-driven sources) as well as the concept of intervention
mapping described above [13,26,27].
Aims 3a and 3b will complete steps 1 to 4 of the intervention
mapping process and lay the foundation for step 5 by pilot
testing the intervention to assess feasibility (aim 3c).
Specifically, we will assess time to complete the intervention,
perceived burden to providers, and patient satisfaction.
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Table 1. Definition of variables for aim 2a.
Variable type and name

Definition

Exposure variables
Patient factors
Age at encounter

Calculated using date of birth CDWa patient domain

Gender

Male or female

Ethnicity or race

As per VHAb convention

Socioeconomic status

GeoScore to zip code to median income

Neurologic level of injury

ICD-10c codes for complete and incomplete quadriplegia and paraplegia

Bladder management strategy

Catheter prescriptions in pharmacy data

Urease-producing organism on culture

Determine positive culture from CDW Micro

Level of pyuria on urinalysis

Use as continuous variable from CDW Micro

Number of clinic visits per year

Use clinic stop code 210 for SCId clinic

Others (as determined by aim 1)

—e

Provider factors
Provider type

Physician, physician assistant

Provider load of SCI patients

Number of SCI patients seen by provider in 2015 and 2016

Others (as determined by Aim 1)

—

Facility factors
Seen at SCI center (hub) or SCI satellite clinic (spoke)

Identify by unique facility codes from majority of visits

Geographical region

Using VAf Citrix Access Groupings for north, south, east, and west

Facility complexity

General knowledge code that is applied to each facility

Presence of antimicrobial stewardship program

Provide results from Healthcare Analysis and Information Group (HAIG)
2012 survey

Others (as determined by aim 1)

—

Outcome variables

a

Urine culture obtained

Identified in CDW microdomain

Antibiotics given for urine within 7 days

Antibiotic prescription noted in CDW outpatient pharmacy domain

CDW: corporate data warehouse.

b

VHA: Veterans Health Administration.

c

ICD-10: International Classification of Disease-10.

d

SCI: spinal cord injury.

e

Not applicable.

f

VA: Veterans Affairs.
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Table 2. Definition of variables for aim 2b.
Variable type and name

Definition

Exposure variable
Antibiotic use

Antibiotics within 7 days of urine culture

Outcome variables (within 60 days of annual evaluation encounter)
Emergency visits

As recorded in CDWa emergency domain

GUb complication

ICD-10c codes for hematuria, urethral stricture, urethral injury, acute
kidney injury, UTId

Admission for GU complication

Presence of an admission with above ICD-10 codes in CDW inpatient
domain

Clostridium difficile infection

Positive culture or toxin result, per CDW micro

Repeat urine culture

Presence of urine culture in CDW microdomain

Diagnosis of GU stone

ICD-10 codes for bladder, ureter, renal calculus

Covariates

a

Age

Calculated using date of birth CDW patient domain

Gender

Male or female

Race or ethnicity

As per VHAe convention

Neurologic level of injury

ICD-10 codes for complete and incomplete quadriplegia and paraplegia

Bladder management strategy

Catheter prescriptions in pharmacy data

CDW: corporate data warehouse.

b

GU: genitourinary.

c

ICD-10: International Classification of Disease-10.

d

UTI: urinary tract infection.

e

VHA: Veterans Health Administration.

Development of Provider and Nursing Intervention
For the provider intervention, the study team will conduct a
series of focus groups with the SCI clinic team (providers and
nurses) to receive feedback on the proposed intervention. The
intervention design will be based on antibiotic stewardship
principles of right drug, right dose, and right duration. The
duration and number of meetings will be determined by the
group and adjusted in response to the pace of progress. The
components of the provider intervention will be refined through
iterative design to address the potential barriers and facilitators
to adoption of their use. Lab order sets will be refined to help
providers not send urinalysis and urine cultures on asymptomatic
patients during the annual evaluation and, if they are
inadvertently sent, to prevent providers from ordering
antibiotics. The current annual evaluation laboratory order set
in the Houston Veterans Affairs electronic medical record
includes a urinalysis and urine culture; this will be removed.
The decision aid will be a pocket card that makes the ASB and
UTI guidelines actionable and, thus, applicable to individual
patients at the point of care. If providers state during focus
groups that having a communication tool would be helpful,
talking points will be developed on how to discuss bladder
management, urine testing, and bacteriuria treatment with
patients during the annual evaluation. Nursing interventions
will include developing a script and symptom checklist for
nurses to use when interacting with patients requesting urine
https://www.researchprotocols.org/2019/2/e12272/
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testing and bacteriuria management during the annual
evaluation. Although the focus of the intervention is on helping
providers decide whether to use antibiotics or not, we will also
provide education and material on how to choose the right drug
given latest information about antibiotic resistance in organisms
causing UTI in SCI.
Attending, resident, and physician extender education sessions
will be incorporated into the weekly SCI lecture series. The first
such meeting will introduce the intervention and underlying
rationale, review the relevant ASB and UTI guidelines, and
explain how and when core components such as order sets will
be introduced. After this initial introductory meeting, the
decision aids and other intervention materials will be given to
all participants. During follow-up sessions, a case example from
the annual evaluation clinic from the prior month will be
discussed using the decision aid to clarify whether management
was or was not compliant with ASB/UTI guidelines. This type
of small-group, case-based audit and feedback was highly
effective in the Kicking CAUTI campaign, as it retains key
characteristics of effective audit and feedback, in that it is
personalized (to the clinic), timely, nonpunitive, and provides
the correct answer [14]. Group discussion will enable providers
to ask questions about other cases they managed recently.
Nursing education and audit and feedback will be done monthly
during nursing in service by the study team.
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Development of Patient Intervention

Declarations

Aim 3b focuses on developing patient intervention materials.
As an analogous intervention to Kicking CAUTI for patients
does not exist, the second part of this aim will focus on ways
to intervene on the patient aspect of urine testing and bacteriuria
management. The intervention components will focus on patient
education on objectives such as understanding neurogenic
bladder and bladder management strategies after SCI and how
the consequences of neurogenic bladder and/or catheterization
place persons at higher risk for bacteriuria. Intervention
components will include a webpage linked to the Texas
Paralyzed Veterans of America (PVA) homepage with
information targeting the above objectives, a paper flyer
summarizing information such as that presented on the website,
as well as talking points on how to ask a provider for more
information on neurogenic bladder and bacteriuria management.
We will create a video that will be housed on the PVA website,
which can be readily accessed on the computers in the clinic
room.

Ethics Approval and Consent to Participate

Aim 3c is to conduct a quasi-experimental pilot study of the
Test Smart, Treat Smart intervention at the Houston VHA. For
providers, the main objectives of this pilot study are to assess
the following: (1) time to use or complete components of the
intervention and (2) perceived burden of using intervention
components. For patients, the main objectives of the pilot study
are to test the following: (1) their quality of life regarding
bladder management before the annual evaluation and (2)
satisfaction with neurogenic bladder management and bacteriuria
testing education received during the annual evaluation. A Test
Smart, Treat Smart kick-off meeting with clinic staff will occur
before the start of the intervention trial. It will also be discussed
at the local PVA meeting the month before the start of the trial.
The trial of the intervention will total 4 months. At the 2- and
4-month marks, providers and patients will participate in
separate focus groups to provide feedback about the intervention.
Patients will receive the SCI-Quality of Life-Bladder
Complication assessment before the annual evaluation
encounter. This is a validated instrument exploring how bladder
management affects patients emotionally, and it has 6 items
specifically for UTI [28]. To assess the fidelity of the
intervention and prudent safety monitoring, we will compare
rates of clinic visits and hospitalizations for UTI/CAUTI before
the intervention, at the midpoint of the intervention, at the end
of the intervention, and 2 months after the intervention.

Analysis for Objective 3
The qualitative responses will be coded and analyzed as
described for objective 1. The SCI-Quality of Life scores will
give us ideas on baseline satisfaction with bladder management
to be used for future effectiveness studies. Descriptive statistics
will be used to analyze the rates of the hospitalization and clinic
visits for UTI/UTI for safety monitoring, and a t test will be
used to analyze the difference in the rates of these outcomes at
different time points.

This protocol has been approved by the Baylor College of
Medicine institutional review board (IRB) and VHA Research
and Development (H-38357).

Aim 1
The qualitative interviews and quantitative surveys will be
performed after verbal informed consent and approved waiver
of written informed consent.

Aim 2
The database analysis will be completed under approved waiver
of informed consent.

Aim 3
The focus groups will be completed after verbal consent is
obtained with approved waiver of written informed consent.
The quasi-experimental study will be completed after verbal
consent is obtained and with approved waiver of written
informed consent.

Results
This protocol received IRB and VHA Research and
Development approval in July 2017, and the funding start date
for the project was November 2017. The initial plan of having
patients complete a Web-based survey had to be abandoned to
achieve IRB approval; phone surveys are being completed
instead, which has proven to be challenging. We have recently
made the addition of a scripted phone message identifying who
we are and why we are calling, informing potential participants
that we are not solicitors. Recruitment for aim 1 is progressing;
as of submission of this manuscript, 10 (67%) of the target goal
of 15 provider interviews were complete, and 77 (77%) of the
target goal of 100 surveys. With regard to patients, 5 (33%) of
the target goal of 15 interviews were complete, and 20 (20%)
of the target goal of 100 surveys had been completed. The study
team plans to present the results for providers in April 2019.
Database analyses for aim 2 will begin in January 2019.

Discussion
Our previous work shows that the resources for effective
antibiotic stewardship programs are more likely to be in place
in VHA facilities with SCI units versus hospitals that do not
[29]. Specifically, VHA facilities with SCI centers are more
likely to have at least 1 full-time infectious diseases physician,
an infectious diseases fellowship program, and a clinical
pharmacist with formal infectious diseases training—all
characteristics that have been shown to decrease antibiotic use
in previous studies [30]. However, deploying these resources
effectively requires a more complete understanding of the
barriers and facilitators of their use, which is the purpose of this
protocol.
We anticipate several challenges in carrying out the work as
described in this protocol. Difficulty in scheduling time for the
provider interviews and surveys due to busy clinic schedules is
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anticipated. The team will work individually with providers to
find a convenient time for their interviews. The study team has
strong contacts with national VHA SCI leadership and will
enlist their help in contacting local SCI leadership in the various
sites to explain our project and encourage participation. We are
aware that a database study cannot provide an explanation for
why a test was done or what factors went into the provider’s
decision to place the order for a test or antibiotics. For this
reason, the findings from our database studies of the clinical
outcomes downstream from the annual urine testing will be
triangulated with our qualitative results. The association we
expect to find between urine tests and higher use of antibiotics,
even potentially Clostridium difficile, will provide evidence to
make our intervention acceptable to end users. In other words,

Skelton et al
if we find that potential harms result from routine urine testing
in SCI, this finding will encourage people to adopt new
practices. The literature supports the concept that interventions
are more likely to be adopted if the evidence base is considered
trustworthy and source of evidence is relevant [31].
Bacteriuria management in persons with SCI is a routine task
that involves complex decision making to be handled in a
guidelines-compliant manner, particularly the given conflicting
guidelines on this topic. Our future work will focus on the
implementation and sustainability of antibiotic stewardship
interventions for bacteriuria in this high-risk population. We
have developed regional and national partners on this work to
increase the likelihood of widespread adoption.
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